Jørgen Slots | Clinical Neuroscience |

Prof. Dr. Jørgen Slots | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jørgen Slots, University of Southern California,  United States.

Dr. Jørgen Slots is an internationally recognized scholar in periodontology and oral microbiology, with a rich academic and professional background rooted in Denmark, the United States, and Sweden. After completing multiple advanced degrees—including a D.D.S., Ph.D., D.M.D., and M.B.A.—he held tenured and leadership roles at esteemed institutions such as the Royal Dental College, SUNYAB, and the University of Göteborg. His research focused on microbial causes of periodontal disease, bridging the gap between laboratory science and clinical treatment. Throughout his career, he has been a pioneer in integrating microbiology into dental education and has significantly influenced both teaching and clinical standards globally. His work continues to inform practices in oral health and inspire the next generation of researchers and clinicians.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born in 1944 in Vejle, Denmark, Dr. Jørgen Slots embarked on a lifelong journey in dentistry and biomedical science that began at the prestigious Royal Dental College in Copenhagen. He earned his D.D.S. in 1969 and continued to delve deeper into academic excellence with an M.S. (Lic. Odont.) in 1974. His passion for periodontology led him to complete postgraduate education in this specialty by 1976, setting the stage for a research-intensive career. Not stopping there, he pursued advanced studies in microbiology at the Forsyth Dental Center in Boston, Massachusetts, where he earned a Certificate in Microbiology in 1977. By 1979, he had completed his doctoral thesis (Dr. Odont./Ph.D.), a reflection of his rigorous scientific training and commitment to academic inquiry.

🧪 Professional Endeavors in Dental Science

Dr. Slots’ career spans both private practice and academia, beginning with clinical work in Copenhagen from 1969 to 1976. However, his true calling was in academia and research, where he quickly rose through the ranks at the Royal Dental College, becoming a tenured associate professor in the Department of Periodontology and Bacteriology. His academic influence extended internationally as he moved to the United States, joining the State University of New York at Buffalo (SUNYAB) as a visiting associate professor in 1977. His multifaceted roles there included teaching, research, and graduate mentorship. In 1982, his expertise was recognized with a professorial and chair appointment at the University of Göteborg in Sweden, where he led the Department of Oral Microbiology until 1986.

🔬 Contributions and Research Focus

Dr. Slots’ core research has focused on periodontal microbiology, particularly the microbial etiology of periodontal diseases and the role of anaerobic bacteria in oral infections. His extensive background in both clinical periodontology and microbiology enabled him to bridge these disciplines, pioneering investigations into microbial pathogenesis, host responses, and antimicrobial therapy. His work at the intersection of dentistry and microbiology has contributed significantly to the understanding of how bacterial biofilms influence periodontal health and disease progression. Through his positions in leading institutions, he has mentored countless students and young researchers in translational oral biology.

🏅 Accolades and Recognition

Throughout his distinguished career, Dr. Slots has earned numerous accolades that acknowledge both his scholarly achievements and teaching excellence. His academic journey includes obtaining a D.M.D. from the University of Pennsylvania in 1986, further consolidating his clinical credentials. In 1989, he expanded his skillset by earning an M.B.A. from the Wharton School, indicating his interest in healthcare administration and leadership. Such accomplishments reflect a rare blend of scientific acumen, clinical expertise, and administrative insight that is seldom seen in one individual. His tenured appointments and leadership roles speak volumes about the respect he commands in his field.

🌍 Impact and Global Influence

Dr. Slots’ contributions have had global implications, influencing not only North American dental education but also shaping European periodontal research. His tenure at institutions in Denmark, Sweden, and the United States illustrates his international standing and thought leadership. By combining laboratory science with clinical application, he has contributed to international standards in oral hygiene practices, periodontal disease diagnostics, and treatment protocols. His collaborative work across continents has helped create a robust, evidence-based approach to periodontal care that is taught and practiced worldwide.

📚 Legacy in Dental Education and Microbiology

As a graduate faculty member and department chair, Dr. Slots played a vital role in curriculum development, graduate training, and interdisciplinary integration of oral microbiology into mainstream dental education. He has influenced a generation of oral biologists and periodontists who continue to build upon his foundational work. His teaching style, grounded in research and clinical relevance, made him a beloved educator and mentor. The ripple effects of his academic stewardship can still be seen in the progressive research and pedagogical models employed at the University of Southern California and other leading dental institutions.

🔭 Future Vision and Continuing Relevance

Though his primary academic career has matured, the legacy of Dr. Slots remains very much alive in ongoing research studies, collaborative clinical trials, and academic dialogues. His integration of clinical practice with microbiological research stands as a model for future dental scientists aiming to address emerging challenges in oral-systemic health. With a unique blend of intellectual rigor and compassionate mentorship, Dr. Slots has laid a foundation that will support future breakthroughs in both academic and applied dental sciences. His life’s work continues to inspire innovation and scientific inquiry in oral health worldwide.

Publication

Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions
A Ashimoto, C Chen, I Bakker, J Slots – 1996

Subgingival microflora and periodontal disease
J Slots – 1979

Periodontitis: facts, fallacies and the future
J Slots – 2017

Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival
J Slots, RJ Genco – 1984

Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases
J Slots, MA Listgarten – 1988

Selective medium for isolation of Actinobacillus actinomycetemcomitans
J Slots – 1982

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: a Cross-Sectional Microbiological Investigation
J Slots, HS Reynolds, RJ Genco – 1980

Diabetes and periodontal diseases: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases
ILC Chapple, R Genco, Working Group 2 of the Joint EFP/AAP Workshop – 2013

The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults
J Slots, L Bragd, M Wikström, G Dahlén – 1986

Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment
J Slots, M Ting – 1999

Antibiotics in periodontal therapy: advantages and disadvantages
J Slots, TE Rams – 1990

The predominant cultivable microflora of advanced periodontitis
J Slots – 1977

Actinobacillus actinomycetemcomitans in Human Periodontal Disease: Prevalence in Patient Groups and Distribution of Biotypes and Serotypes Within Families
JJ Zambon, LA Christersson, J Slots – 1983

Systemic antibiotic therapy in periodontics
AJV Winkelhoff, TE Rams, J Slots – 1996

Microbial differences in 2 clinically distinct types of failures of osseointegrated implants
ES Rosenberg, JP Torosian, J Slots – 1991

The predominant cultivable organisms in juvenile periodontitis
J Slots – 1976

Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline
J Slots, BG Rosling – 1983

Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing, and of adjunctive tetracycline therapy
J Slots, P Mashimo, MJ Levine, RJ Genco – 1979

Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease
JJ Zambon, J Slots, RJ Genco – 1983

🏁 Conclusion

Dr. Jørgen Slots’ career stands as a remarkable example of interdisciplinary excellence in dental science. Through his research in periodontal microbiology, leadership in academic institutions, and dedication to global dental education, he has left a lasting legacy. His contributions have not only advanced scientific knowledge but also improved clinical approaches to oral healthcare worldwide. Dr. Slots remains a towering figure whose impact resonates in the fields of periodontology, microbiology, and beyond.

Takeshi Sakurai | Neuroanatomy | Best Researcher Award

Prof. Dr. Takeshi Sakurai | Neuroanatomy | Best Researcher Award

Prof. Dr. Takeshi Sakurai, University of Tsukuba, Japan.

Takeshi Sakurai, M.D., Ph.D., is a distinguished academic whose career spans across key positions in neuroscience, pharmacology, and integrative sleep medicine. After earning his M.D. and Ph.D. from the University of Tsukuba, he embarked on a journey of groundbreaking research, primarily focusing on neurotransmission and sleep regulation. Sakurai’s postdoctoral work in prestigious institutions, coupled with his leadership of major projects like the Yanagisawa Orphan Receptor Project, established him as a leader in molecular neuroscience. Over the years, he has earned recognition through accolades and significant academic positions, including his current role as Professor and Vice Director at the University of Tsukuba’s International Institute for Integrative Sleep Medicine. His research continues to shape the understanding of sleep and brain function, while his influence extends to mentoring the next generation of scientists.

Profile

Google Scholar

Early Academic Pursuits 📚


Takeshi Sakurai’s academic journey began with his medical studies at the University of Tsukuba, where he earned his M.D. in 1989. During his early years at the university, he developed a keen interest in the molecular mechanisms of biological systems. This curiosity led him to pursue a Ph.D. in medicine, which he completed in 1993. His doctoral research focused on the cloning of a cDNA encoding a non-isopetide-selective subtype of the endothelin receptor, a project that was published in Nature in 1990, marking the beginning of his significant contributions to molecular pharmacology.

Professional Endeavors 👨‍⚕️


Following his Ph.D., Sakurai embarked on a promising career in academic research, starting as a postdoctoral fellow at the Institute of Basic Medical Sciences in 1993. His career rapidly advanced as he took on various roles, including Assistant Professor at the same institute. During his tenure, he also worked as a postdoctoral fellow at the prestigious Howard Hughes Medical Institute at the University of Texas Southwestern Medical Center in Dallas from 1995 to 1996. These experiences broadened his expertise in pharmacology and molecular neuroscience, laying the foundation for his future academic leadership roles. By 1999, he became an Associate Professor at the University of Tsukuba and contributed significantly to the university’s research landscape.

Contributions and Research Focus 🧬


Sakurai’s research is primarily centered around molecular neuroscience, pharmacology, and integrative physiology. His work has been pivotal in advancing the understanding of biological systems and their regulation at the molecular level. Notably, his leadership of the Yanagisawa Orphan Receptor Project under the Exploratory Research for Advanced Technology (ERATO) of the Japan Science and Technology Corporation highlights his role in pioneering research on orphan receptors. His continued focus on the mechanisms of neurotransmission and their involvement in sleep regulation has earned him a place as a leading researcher in the field of integrative sleep medicine.

Accolades and Recognition 🏆


Throughout his career, Sakurai has earned widespread recognition for his contributions to medicine and neuroscience. His groundbreaking work on neurotransmitter systems and sleep regulation has led to his appointment as a Professor and Vice Director at the University of Tsukuba’s International Institute for Integrative Sleep Medicine. His research has not only shaped the scientific community’s understanding of brain function but also garnered him numerous accolades, further cementing his reputation as a thought leader in the field.

Impact and Influence 🌍


Sakurai’s impact extends far beyond his own research. As a professor, he has mentored countless students and researchers who have gone on to make their own significant contributions in the fields of neuroscience and pharmacology. His interdisciplinary approach to sleep medicine has influenced research on neurodegenerative diseases, mental health, and drug development. The work he has pioneered in molecular neuroscience has also paved the way for advances in treatment approaches for disorders related to sleep and neurotransmission, offering hope for improved therapeutic interventions.

Legacy and Future Contributions 🔬


Looking ahead, Sakurai’s legacy in neuroscience and integrative sleep medicine is poised to continue influencing both academic research and clinical practice. His innovative research on sleep regulation and the molecular mechanisms underpinning brain function will undoubtedly remain foundational in the future of both basic and applied medical sciences. As he continues his work at the University of Tsukuba, Sakurai’s future contributions will likely expand our understanding of the brain’s intricate systems and their broader implications for human health. His career exemplifies a dedication to advancing science, and his ongoing research promises to address critical challenges in medicine and health.

Academic Leadership and Mentorship 🎓


In addition to his personal research achievements, Sakurai’s role in academic leadership cannot be understated. As a professor at the University of Tsukuba, he has played a pivotal role in shaping the institution’s research direction and academic programs, particularly within the fields of integrative physiology and sleep medicine. His influence extends through the mentorship of students, guiding the next generation of researchers who will continue to build on his work. Sakurai’s commitment to education and his support for innovative research initiatives are key to his lasting impact on the academic and medical communities.

Publication

  • Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
    Authors: T Sakurai, A Amemiya, M Ishii, I Matsuzaki, RM Chemelli, H Tanaka, …
    Year: 1998

 

  • Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
    Authors: T Sakurai, M Yanagisawa, Y Takuwat, H Miyazakit, S Kimura, K Goto, …
    Year: 1990

 

  • Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity
    Authors: J Hara, CT Beuckmann, T Nambu, JT Willie, RM Chemelli, CM Sinton, …
    Year: 2001

 

  • Autism genome-wide copy number variation reveals ubiquitin and neuronal genes
    Authors: JT Glessner, K Wang, G Cai, O Korvatska, CE Kim, S Wood, H Zhang, …
    Year: 2009

 

  • The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
    Author: T Sakurai
    Year: 2007

 

  • Distribution of orexin neurons in the adult rat brain
    Authors: T Nambu, T Sakurai, K Mizukami, Y Hosoya, M Yanagisawa, K Goto
    Year: 1999

 

  • Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems
    Authors: Y Date, Y Ueta, H Yamashita, H Yamaguchi, S Matsukura, K Kangawa, …
    Year: 1999

 

  • Hypothalamic orexin neurons regulate arousal according to energy balance in mice
    Authors: A Yamanaka, CT Beuckmann, JT Willie, J Hara, N Tsujino, M Mieda, …
    Year: 2003

 

  • Plastic stress-strain matrix and its application for the solution of elastic-plastic problems by the finite element method
    Authors: Y Yamada, N Yoshimura, T Sakurai
    Year: 1968

 

  • Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area
    Authors: CF Elias, CB Saper, E Maratos‐Flier, NA Tritos, C Lee, J Kelly, JB Tatro, …
    Year: 1998

 

Conclusion


Takeshi Sakurai’s work has profoundly impacted the fields of neuroscience, pharmacology, and sleep medicine. His contributions have not only advanced scientific understanding but have also paved the way for practical applications in medical therapies. Through his leadership and mentorship, Sakurai’s legacy is set to endure, with his future research promising further advancements in understanding the complexities of the brain and its regulation. His dedication to advancing both science and education ensures that his influence will continue to resonate in academic and clinical circles for years to come.

 

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Hanaa Ali | Neurotoxicity | Best Researcher Award

Prof. Hanaa Ali | Neurotoxicity | Best Researcher Award

Prof. Hanaa Ali, National Research Centre, Egypt.

Dr. Hanaa Mahmoud Sayed Ali is a distinguished Egyptian researcher specializing in Biology, Zoology, and Molecular Genetics. With a Ph.D. in Zoology (Genetics and Cytology) from Ain Shams University, she has a career spanning over 25 years, contributing significantly to academic research and teaching.Her research contributions include membership in several scientific research groups and administrative roles that enhance student development and academic governance. Dr. Hanaa is an active member of several scientific societies, contributing to advancements in radiological, nuclear, and medical research.

 

profile

Scopus

🎓 Educational Background

Ph.D. in Zoology (Genetics and Cytology),Faculty of Science, Ain Shams University, 2008.M.Sc. in ZoologyFaculty of Science, Ain Shams University, 2003.B.Sc. in Zoology,Faculty of Science, Ain Shams University, June 1997 (Grade: Very Good ).

🏢 Professional Career

Professor Researcher (National Research Centre, Cairo, Egypt), From 16/11/2023 – Present.Assistant Researcher Professor (National Research Centre, Cairo, Egypt). 30/09/2018 – 15/11/2023.Assistant Professor (Common First Year Deanship, King Saud University, Saudi Arabia),28/09/2010 – 31/08/2020 (Health Track Supervisor).Researcher (National Research Centre, Cairo, Egypt),31/07/2008 – 29/09/2018.Researcher Assistant (National Research Centre, Cairo, Egypt),08/05/2004 – 30/07/2008.Fellowship (Demonstrator) (Faculty of Science, Ain Shams University).1998 – 2003.Part-Time Demonstrator (Faculty of Dentistry, 6th of October University),1999 – 2001.

📚 Teaching Experience

Zoology and Histology Courses for various disciplines:Dentistry, Pharmacy, and Science faculties.Topics include Cytology, Histology, Physiology, Parasitology, Invertebrates, Vertebrates, and Genetics.

🔬 Research Projects

Pharmacology Project (Research Group No. RG-1438-061),Deanship of Scientific Research, King Saud University.Pharmacology and Toxicology Projects,Research Group Nos. RG-1439-017 and RG-1439-638Deanship of Scientific Research, King Saud University

🛠️ Administrative Experience

Supervision of Health Track (Common First Year Deanship, King Saud University).Committee Memberships Review student problems .Establishment of Advisory Council .Course accommodations  (Buildings 25 & 26).Scheduling Committee.

🌐 Memberships in Scientific Societies

Member of the Scientific Professions Syndicate.Member of the Egyptian Society for Radiological Sciences and Its Applications.Member of the Egyptian Society for Nuclear Sciences and Its Applications.Member of the Scientific Society for Medical Research.

📚 Publications

  • Genetic Profile of Gamma Irradiated Locusta migratoria migratorioides: A Futuristic Eco-friendly Control Approach
    • Authors: Ali, H.M.; Fathy, Z.; Ibrahim, S.S.; Sayed, R.M.
    • Year: 2024

 

  • Estimating the Impact of Gamma Radiation on Biochemical Aspects and DNA Damage by Comet Assay in Galleria mellonella Male
    • Authors: Afify, A.; Ali, H.M.; Sayed, R.M.
    • Year: 2024

 

  • Fischer’s Oligopeptide Ratio in Ischemic Hypoxia: Prophylactic Amendment of Sophoretin and Melatonin Supplementation
    • Authors: Kadry, M.O.; Ali, H.M.
    • Year: 2024

 

  • Involvement of Nrf2, JAK and COX Pathways in Acetaminophen-Induced Nephropathy: Role of Some Antioxidants
    • Authors: Alqahtani, Q.H.; Fadda, L.M.; Alhusaini, A.M.; Hasan, I.H.; Ali, H.M.
    • Year: 2023

 

  • Impact of HIF1-α/TGF-β/Smad-2/Bax/Bcl2 Pathways on Cobalt Chloride-Induced Cardiac and Hepatorenal Dysfunction
    • Authors: Kadry, M.O.; Ali, H.M.
    • Year: 2023

 

  • Genetic Diversity of Irradiated Galleria mellonella with Sub-Sterile and Sterile Doses Assessed by SCOT
    • Authors: Ali, H.M.; Sayed, R.M.
    • Year: 2022

 

  • Nano-Resveratrol: A Promising Candidate for the Treatment of Renal Toxicity Induced by Doxorubicin in Rats Through Modulation of Beclin-1 and mTOR
    • Authors: Alhusaini, A.M.; Fadda, L.M.; Alanazi, A.M.; Hasan, I.H.; Ali, R.A.
    • Year: 2022

 

  • The Potential Protective Effect of Curcumin and α-Lipoic Acid on N-(4-Hydroxyphenyl) Acetamide-Induced Hepatotoxicity Through Downregulation of α-SMA and Collagen III Expression
    • Authors: Alhusain, A.; Fadda, L.; Sarawi, W.; Hasan, I.; Badr, A.
    • Year: 2022

 

  • Chitosan Nanoparticles as a Promising Candidate for Liver Injury Induced by 2-Nitropropane: Implications of P53, iNOS, VEGF, PCNA, and CD68 Pathways
    • Authors: Shaheen, S.; Arafah, M.M.; Alshanwani, A.R.; Alharbi, F.M.B.; AlHarthii, A.
    • Year: 2021

 

  • Manipulation of Quercetin and Melatonin in the Down-Regulation of HIF-1α, HSP-70, and VEGF Pathways in Rat’s Kidneys Induced by Hypoxic Stress
    • Authors: Alshanwani, A.R.; Shaheen, S.; Faddah, L.M.; Alharbi, F.M.B.; AlHarthii, A.
    • Year: 2020

 

Conclusion

Dr. Hanaa Mahmoud Sayed Ali exemplifies excellence in academia and research. Her extensive experience, dedication to teaching, and contributions to interdisciplinary projects highlight her as a leader in her field. With a strong foundation in Zoology and Genetics, she continues to drive impactful research and inspire future generations of scientists.